QQ客服 官方微博 反馈留言

	Discovery of Novel Pazopanib-Based HDAC and VEGFR Dual Inhibitors Targeting Cancer Epigenetics and Angiogenesis Simultaneously
	Zang, Jie; Liang, Xuewu; Huang, Yongxue; Jia, Yuping; Li, Xiaoyang; Xu, Wenfang; Chou, C. James; Zhang, Yingjie
刊名	JOURNAL OF MEDICINAL CHEMISTRY
	2018
卷号	61期号:12页码:5304-5322
DOI	10.1021/acs.jmedchem.8b00384
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4569040
专题	山东大学
作者单位	1.Shandong Univ, Sch Pharmaceut Sci, Dept Med Chem, Jinan 250012, Shandong, Peoples R China. 2.[
推荐引用方式 GB/T 7714	Zang, Jie,Liang, Xuewu,Huang, Yongxue,et al. Discovery of Novel Pazopanib-Based HDAC and VEGFR Dual Inhibitors Targeting Cancer Epigenetics and Angiogenesis Simultaneously[J]. JOURNAL OF MEDICINAL CHEMISTRY,2018,61(12):5304-5322.
APA	Zang, Jie.,Liang, Xuewu.,Huang, Yongxue.,Jia, Yuping.,Li, Xiaoyang.,...&Zhang, Yingjie.(2018).Discovery of Novel Pazopanib-Based HDAC and VEGFR Dual Inhibitors Targeting Cancer Epigenetics and Angiogenesis Simultaneously.JOURNAL OF MEDICINAL CHEMISTRY,61(12),5304-5322.
MLA	Zang, Jie,et al."Discovery of Novel Pazopanib-Based HDAC and VEGFR Dual Inhibitors Targeting Cancer Epigenetics and Angiogenesis Simultaneously".JOURNAL OF MEDICINAL CHEMISTRY 61.12(2018):5304-5322.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。